ABSTRACT
Macrophages are found in close proximity with collagen-producing myofibroblasts and indisputably play a key role in fibrosis. They produce profibrotic mediators that directly activate fibroblasts, including transforming growth factor-β1 and platelet-derived growth factor, and control extracellular matrix turnover by regulating the balance of various matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases. Macrophages also regulate fibrogenesis by secreting chemokines that recruit fibroblasts and other inflammatory cells. With their potential to act in both a pro- and antifibrotic capacity, as well as their ability to regulate the activation of resident and recruited myofibroblasts, macrophages and the factors they express are integrated into all stages of the fibrotic process. These various, and sometimes opposing, functions may be performed by distinct macrophage subpopulations, the identification of which is a growing focus of fibrosis research. Although collagen-secreting myofibroblasts once were thought of as the master “producers” of fibrosis, this review will illustrate how macrophages function as the master “regulators” of fibrosis.
KEYWORDS
Fibrosis - inflammation - collagen - wound healing - stellate cell - myofibroblasts - interleukin-13 - transforming growth factor beta - tumor necrosis factor - interleukin-1 - interleukin-17 - arginase - Relm-alpha - chitinase
REFERENCES
1
Bataller R, Brenner D A.
Liver fibrosis.
J Clin Invest.
2005;
115
209-218
2
Iredale J P.
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.
J Clin Invest.
2007;
117
539-548
3
Friedman S L.
Mechanisms of hepatic fibrogenesis.
Gastroenterology.
2008;
134
1655-1669
4
Friedman S L.
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.
Physiol Rev.
2008;
88
125-172
5
Wallace K, Burt A D, Wright M C.
Liver fibrosis.
Biochem J.
2008;
411
1-18
6
Luckey S W, Petersen D R.
Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats.
Exp Mol Pathol.
2001;
71
226-240
7
Ramadori G, Armbrust T.
Cytokines in the liver.
Eur J Gastroenterol Hepatol.
2001;
13
777-784
8
Ramm G A, Nair V G, Bridle K R, Shepherd R W, Crawford D H.
Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.
Am J Pathol.
1998;
153
527-535
9
Leicester K L, Olynyk J K, Brunt E M, Britton R S, Bacon B R.
CD14-positive hepatic monocytes/macrophages increase in hereditary hemochromatosis.
Liver Int.
2004;
24
446-451
10
Thompson R W, Pesce J T, Ramalingam T et al..
Cationic amino acid transporter-2 regulates immunity by modulating arginase activity.
PLoS Pathog.
2008;
4
e1000023
11
Friedman S L, Arthur M J.
Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors.
J Clin Invest.
1989;
84
1780-1785
12
Wahl S M, McCartney-Francis N, Allen J B, Dougherty E B, Dougherty S F.
Macrophage production of TGF-beta and regulation by TGF-beta.
Ann N Y Acad Sci.
1990;
593
188-196
13
Bonner J C, Osornio-Vargas A R, Badgett A, Brody A R.
Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, -AB, and -BB isoforms secreted by rat alveolar macrophages.
Am J Respir Cell Mol Biol.
1991;
5
539-547
14
Wynn T A.
Cellular and molecular mechanisms of fibrosis.
J Pathol.
2008;
214
199-210
15
Gasse P, Mary C, Guenon I et al..
IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.
J Clin Invest.
2007;
117
3786-3799
16
Kaviratne M, Hesse M, Leusink M et al..
IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent.
J Immunol.
2004;
173
4020-4029
17
Olman M A.
Beyond TGF-beta: a prostaglandin promotes fibrosis.
Nat Med.
2009;
15
1360-1361
18
Oga T, Matsuoka T, Yao C et al..
Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta.
Nat Med.
2009;
15
1426-1430
19
Duffield J S, Forbes S J, Constandinou C M et al..
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.
J Clin Invest.
2005;
115
56-65
20
Hotchkiss R S, Strasser A, McDunn J E, Swanson P E.
Cell death.
N Engl J Med.
2009;
361
1570-1583
21
Rock K L, Kono H.
The inflammatory response to cell death.
Annu Rev Pathol.
2008;
3
99-126
22
Fadok V A, Bratton D L, Konowal A, Freed P W, Westcott J Y, Henson P M.
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
J Clin Invest.
1998;
101
890-898
23
Takehara T, Tatsumi T, Suzuki T et al..
Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses.
Gastroenterology.
2004;
127
1189-1197
24
Iredale J P, Benyon R C, Pickering J et al..
Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.
J Clin Invest.
1998;
102
538-549
25
Wynn T A.
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.
J Clin Invest.
2007;
117
524-529
26
Otogawa K, Kinoshita K, Fujii H et al..
Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis.
Am J Pathol.
2007;
170
967-980
27
Shi J, Aisaki K, Ikawa Y, Wake K.
Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride.
Am J Pathol.
1998;
153
515-525
28
Patsenker E, Popov Y, Stickel F, Jonczyk A, Goodman S L, Schuppan D.
Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Gastroenterology.
2008;
135
660-670
29
Douglass A, Wallace K, Parr R et al..
Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury.
J Hepatol.
2008;
49
88-98
30
Atabai K, Jame S, Azhar N et al..
Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages.
J Clin Invest.
2009;
119
3713-3722
31
Sanderson N, Factor V, Nagy P et al..
Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.
Proc Natl Acad Sci U S A.
1995;
92
2572-2576
32
Bissell D M, Wang S S, Jarnagin W R, Roll F J.
Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation.
J Clin Invest.
1995;
96
447-455
33
Gabbiani G.
The myofibroblast in wound healing and fibrocontractive diseases.
J Pathol.
2003;
200
500-503
34
Karlmark K R, Weiskirchen R, Zimmermann H W et al..
Hepatic recruitment of the inflammatory Gr1 + monocyte subset upon liver injury promotes hepatic fibrosis.
Hepatology.
2009;
50
261-274
35
Lin S L, Castaño A P, Nowlin B T, Lupher Jr M L, Duffield J S.
Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations.
J Immunol.
2009;
183
6733-6743
36
Gressner A M, Weiskirchen R, Breitkopf K, Dooley S.
Roles of TGF-beta in hepatic fibrosis.
Front Biosci.
2002;
7
d793-d807
37
Kitani A, Fuss I, Nakamura K, Kumaki F, Usui T, Strober W.
Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis.
J Exp Med.
2003;
198
1179-1188
38
Schmid-Kotsas A, Gross H J, Menke A et al..
Lipopolysaccharide-activated macrophages stimulate the synthesis of collagen type I and C-fibronectin in cultured pancreatic stellate cells.
Am J Pathol.
1999;
155
1749-1758
39
Cameron R G, Blendis L M, Neuman M G.
Accumulation of macrophages in primary sclerosing cholangitis.
Clin Biochem.
2001;
34
195-201
40
Xing Z, Tremblay G M, Sime P J, Gauldie J.
Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation.
Am J Pathol.
1997;
150
59-66
41
Lee C G, Homer R J, Zhu Z et al..
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).
J Exp Med.
2001;
194
809-821
42
Fattouh R, Jordana M.
TGF-beta, eosinophils and IL-13 in allergic airway remodeling: a critical appraisal with therapeutic considerations.
Inflamm Allergy Drug Targets.
2008;
7
224-236
43
Fattouh R, Midence N G, Arias K et al..
Transforming growth factor-beta regulates house dust mite-induced allergic airway inflammation but not airway remodeling.
Am J Respir Crit Care Med.
2008;
177
593-603
44
Ide M, Kuwamura M, Kotani T, Sawamoto O, Yamate J.
Effects of gadolinium chloride (GdCl(3)) on the appearance of macrophage populations and fibrogenesis in thioacetamide-induced rat hepatic lesions.
J Comp Pathol.
2005;
133
92-102
45
Taylor P R, Martinez-Pomares L, Stacey M, Lin H H, Brown G D, Gordon S.
Macrophage receptors and immune recognition.
Annu Rev Immunol.
2005;
23
901-944
46
Szabo G, Mandrekar P, Dolganiuc A.
Innate immune response and hepatic inflammation.
Semin Liver Dis.
2007;
27
339-350
47
Meneghin A, Hogaboam C M.
Infectious disease, the innate immune response, and fibrosis.
J Clin Invest.
2007;
117
530-538
48
Seki E, De Minicis S, Osterreicher C H et al..
TLR4 enhances TGF-beta signaling and hepatic fibrosis.
Nat Med.
2007;
13
1324-1332
49
Marra F, DeFranco R, Grappone C et al..
Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E.
J Investig Med.
1999;
47
66-75
50
Tsuneyama K, Harada K, Yasoshima M et al..
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
J Pathol.
2001;
193
102-109
51
Seki E, de Minicis S, Inokuchi S et al..
CCR2 promotes hepatic fibrosis in mice.
Hepatology.
2009;
50
185-197
52
Okuma T, Terasaki Y, Kaikita K et al..
C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
J Pathol.
2004;
204
594-604
53
Seki E, De Minicis S, Gwak G Y et al..
CCR1 and CCR5 promote hepatic fibrosis in mice.
J Clin Invest.
2009;
119
1858-1870
54
Keane M P, Belperio J A, Moore T A et al..
Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
J Immunol.
1999;
162
5511-5518
55
Kohan M, Bader R, Puxeddu I, Levi-Schaffer F, Breuer R, Berkman N.
Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling.
Clin Exp Allergy.
2007;
37
1444-1454
56
Berman J S, Serlin D, Li X et al..
Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice.
Am J Physiol Lung Cell Mol Physiol.
2004;
286
L1311-L1318
57
Kawashima R, Mochida S, Matsui A et al..
Expression of osteopontin in Kupffer cells and hepatic macrophages and stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas.
Biochem Biophys Res Commun.
1999;
256
527-531
58
Persy V P, Verhulst A, Ysebaert D K, De Greef K E, De Broe M E.
Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice.
Kidney Int.
2003;
63
543-553
59
Sahai A, Malladi P, Melin-Aldana H, Green R M, Whitington P F.
Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
Am J Physiol Gastrointest Liver Physiol.
2004;
287
G264-G273
60
Lorena D, Darby I A, Gadeau A P et al..
Osteopontin expression in normal and fibrotic liver. altered liver healing in osteopontin-deficient mice.
J Hepatol.
2006;
44
383-390
61
Wang Y, Mochida S, Kawashima R et al..
Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acnes-treated rat liver.
J Gastroenterol.
2000;
35
696-701
62
Martinet Y, Rom W N, Grotendorst G R, Martin G R, Crystal R G.
Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis.
N Engl J Med.
1987;
317
202-209
63
Bonner J C.
Regulation of PDGF and its receptors in fibrotic diseases.
Cytokine Growth Factor Rev.
2004;
15
255-273
64
Yoshiji H, Noguchi R, Kuriyama S et al..
Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.
Am J Physiol Gastrointest Liver Physiol.
2005;
288
G907-G913
65
Zhang Y, Lee T C, Guillemin B, Yu M C, Rom W N.
Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure.
J Immunol.
1993;
150
4188-4196
66
Kolb M, Margetts P J, Anthony D C, Pitossi F, Gauldie J.
Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.
J Clin Invest.
2001;
107
1529-1536
67
Wilson M S, Madala S K, Ramalingam T R et al..
Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent.
J Exp Med.
2010;
207
535-552
68
Tiggelman A M, Boers W, Linthorst C, Sala M, Chamuleau R A.
Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma.
J Hepatol.
1995;
23
307-317
69
Mancini R, Benedetti A, Jezequel A M.
An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver.
Virchows Arch.
1994;
424
25-31
70
Leyland H, Gentry J, Arthur M J, Benyon R C.
The plasminogen-activating system in hepatic stellate cells.
Hepatology.
1996;
24
1172-1178
71
Salgado S, Garcia J, Vera J et al..
Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy.
Mol Ther.
2000;
2
545-551
72
Henderson N C, Mackinnon A C, Farnworth S L et al..
Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis.
Am J Pathol.
2008;
172
288-298
73
Wynes M W, Riches D W.
Induction of macrophage insulin-like growth factor-I expression by the Th2 cytokines IL-4 and IL-13.
J Immunol.
2003;
171
3550-3559
74
Büttner C, Skupin A, Reimann T et al..
Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4.
Am J Respir Cell Mol Biol.
1997;
17
315-325
75
Hayashi N, Matsui K, Tsutsui H et al..
Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens.
J Immunol.
1999;
163
6702-6711
76
Wynn T A.
Fibrotic disease and the T(H)1/T(H)2 paradigm.
Nat Rev Immunol.
2004;
4
583-594
77
Chiaramonte M G, Donaldson D D, Cheever A W, Wynn T A.
An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.
J Clin Invest.
1999;
104
777-785
78
Oriente A, Fedarko N S, Pacocha S E, Huang S K, Lichtenstein L M, Essayan D M.
Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts.
J Pharmacol Exp Ther.
2000;
292
988-994
79
Murray L A, Argentieri R L, Farrell F X et al..
Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
Int J Biochem Cell Biol.
2008;
40
2174-2182
80
Hashimoto S, Gon Y, Takeshita I, Maruoka S, Horie T.
IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway.
J Allergy Clin Immunol.
2001;
107
1001-1008
81
Wynn T A, Cheever A W, Jankovic D et al..
An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection.
Nature.
1995;
376
594-596
82
Shi Z, Wakil A E, Rockey D C.
Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses.
Proc Natl Acad Sci U S A.
1997;
94
10663-10668
83
Chiaramonte M G, Cheever A W, Malley J D, Donaldson D D, Wynn T A.
Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis.
Hepatology.
2001;
34
273-282
84
Hoffmann K F, Cheever A W, Wynn T A.
IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis.
J Immunol.
2000;
164
6406-6416
85
Pesce J, Kaviratne M, Ramalingam T R et al..
The IL-21 receptor augments Th2 effector function and alternative macrophage activation.
J Clin Invest.
2006;
116
2044-2055
86
Reiman R M, Thompson R W, Feng C G et al..
Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity.
Infect Immun.
2006;
74
1471-1479
87
Weng H L, Liu Y, Chen J L et al..
The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis.
Hepatology.
2009;
50
230-243
88
Hesse M, Cheever A W, Jankovic D, Wynn T A.
NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease.
Am J Pathol.
2000;
157
945-955
89
Hesse M, Modolell M, La Flamme A C et al..
Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.
J Immunol.
2001;
167
6533-6544
90
Gordon S.
Alternative activation of macrophages.
Nat Rev Immunol.
2003;
3
23-35
91
Pesce J T, Ramalingam T R, Mentink-Kane M M et al..
Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis.
PLoS Pathog.
2009;
5
e1000371
92
Song E, Ouyang N, Hörbelt M, Antus B, Wang M, Exton M S.
Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts.
Cell Immunol.
2000;
204
19-28
93
Goerdt S, Orfanos C E.
Other functions, other genes: alternative activation of antigen-presenting cells.
Immunity.
1999;
10
137-142
94
Doyle A G, Herbein G, Montaner L J et al..
Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma.
Eur J Immunol.
1994;
24
1441-1445
95
Stein M, Keshav S, Harris N, Gordon S.
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.
J Exp Med.
1992;
176
287-292
96 Gordon S. Macrophages and the immune response . In: Paul WE Fundamental Immunology. Philadelphia; Lippincott-Raven Publishers 1999: 533-544
97
Modolell M, Corraliza I M, Link F, Soler G, Eichmann K.
Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines.
Eur J Immunol.
1995;
25
1101-1104
98
Schebesch C, Kodelja V, Müller C et al..
Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro.
Immunology.
1997;
92
478-486
99
MacLeod C L.
Regulation of cationic amino acid transporter (CAT) gene expression.
Biochem Soc Trans.
1996;
24
846-852
100
Gangadharan B, Hoeve M A, Allen J E et al..
Murine gammaherpesvirus-induced fibrosis is associated with the development of alternatively activated macrophages.
J Leukoc Biol.
2008;
84
50-58
101
Migliaccio C T, Buford M C, Jessop F, Holian A.
The IL-4Ralpha pathway in macrophages and its potential role in silica-induced pulmonary fibrosis.
J Leukoc Biol.
2008;
83
630-639
102
Prasse A, Pechkovsky D V, Toews G B et al..
A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.
Am J Respir Crit Care Med.
2006;
173
781-792
103
El Kasmi K C, Qualls J E, Pesce J T et al..
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.
Nat Immunol.
2008;
9
1399-1406
104
Frey A B.
Myeloid suppressor cells regulate the adaptive immune response to cancer.
J Clin Invest.
2006;
116
2587-2590
105
Loke P, Nair M G, Guiliano D et al..
IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype.
Biomed Central.
2002;
3
7
106
Raes G, Baetselier P D, Noel W et al..
Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages.
J Leukoc Biol.
2002;
71
597-602
107
Sandler N G, Mentink-Kane M M, Cheever A W, Wynn T A.
Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair.
J Immunol.
2003;
171
3655-3667
108
Holcomb I N, Kabakoff R C, Chan B et al..
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family.
EMBO J.
2000;
19
4046-4055
109
Gerstmayer B, Küsters D, Gebel S et al..
Identification of RELMgamma, a novel resistin-like molecule with a distinct expression pattern.
Genomics.
2003;
81
588-595
110
Bełtowski J.
Adiponectin and resistin—new hormones of white adipose tissue.
Med Sci Monit.
2003;
9
RA55-RA61
111
Liu T, Jin H, Ullenbruch M et al..
Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6.
J Immunol.
2004;
173
3425-3431
112
Stütz A M, Pickart L A, Trifilieff A, Baumruker T, Prieschl-Strassmayr E, Woisetschläger M.
The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism.
J Immunol.
2003;
170
1789-1796
113
Nair M G, Cochrane D W, Allen J E.
Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro.
Immunol Lett.
2003;
85
173-180
114
Edwards J P, Zhang X, Frauwirth K A, Mosser D M.
Biochemical and functional characterization of three activated macrophage populations.
J Leukoc Biol.
2006;
80
1298-1307
115
Raes G, Noël W, Beschin A, Brys L, de Baetselier P, Hassanzadeh G H.
FIZZ1 and Ym as tools to discriminate between differentially activated macrophages.
Dev Immunol.
2002;
9
151-159
116
Liu T, Dhanasekaran S M, Jin H et al..
FIZZ1 stimulation of myofibroblast differentiation.
Am J Pathol.
2004;
164
1315-1326
117
Liu T, Hu B, Choi Y Y et al..
Notch1 signaling in FIZZ1 induction of myofibroblast differentiation.
Am J Pathol.
2009;
174
1745-1755
118
Chung M J, Liu T, Ullenbruch M, Phan S H.
Antiapoptotic effect of found in inflammatory zone (FIZZ)1 on mouse lung fibroblasts.
J Pathol.
2007;
212
180-187
119
Mishra A, Wang M, Schlotman J et al..
Resistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung.
Am J Physiol Lung Cell Mol Physiol.
2007;
293
L305-L313
120
Anthony R M, Urban Jr J F, Alem F et al..
Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites.
Nat Med.
2006;
12
955-960
121
Loke P, Gallagher I, Nair M G et al..
Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection.
J Immunol.
2007;
179
3926-3936
122
Reece J J, Siracusa M C, Scott A L.
Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophages.
Infect Immun.
2006;
74
4970-4981
123
Anthony R M, Rutitzky L I, Urban Jr J F, Stadecker M J, Gause W C.
Protective immune mechanisms in helminth infection.
Nat Rev Immunol.
2007;
7
975-987
124
Wilson M S, Mentink-Kane M M, Pesce J T, Ramalingam T R, Thompson R, Wynn T A.
Immunopathology of schistosomiasis.
Immunol Cell Biol.
2007;
85
148-154
125
Nair M G, Gallagher I J, Taylor M D et al..
Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells.
Infect Immun.
2005;
73
385-394
126
Pesce J T, Ramalingam T R, Wilson M S et al..
Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity.
PLoS Pathog.
2009;
5
e1000393
127
Nair M G, Du Y, Perrigoue J G et al..
Alternatively activated macrophage-derived RELM-alpha is a negative regulator of type 2 inflammation in the lung.
J Exp Med.
2009;
206
937-952
128
Guan S P, Mok Y K, Koo K N, Chu K L, Wong W S.
Chitinases: biomarkers for human diseases.
Protein Pept Lett.
2009;
16
490-498
129
Sutherland T E, Maizels R M, Allen J E.
Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies.
Clin Exp Allergy.
2009;
39
943-955
130
Reese T A, Liang H E, Tager A M et al..
Chitin induces accumulation in tissue of innate immune cells associated with allergy.
Nature.
2007;
447
92-96
131
Zhu Z, Zheng T, Homer R J et al..
Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation.
Science.
2004;
304
1678-1682
132
Lee C G, Hartl D, Lee G R et al..
Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.
J Exp Med.
2009;
206
1149-1166
133
Boot R G, Renkema G H, Strijland A, van Zonneveld A J, Aerts J M.
Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages.
J Biol Chem.
1995;
270
26252-26256
134
Malaguarnera L.
Chitotriosidase: the yin and yang.
Cell Mol Life Sci.
2006;
63
3018-3029
135
Malaguarnera L, Di Rosa M, Zambito A M, dell'Ombra N, Nicoletti F, Malaguarnera M.
Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease.
Gut.
2006;
55
1313-1320
136
Malaguarnera L, Rosa M D, Zambito A M, dell'Ombra N, Marco R D, Malaguarnera M.
Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution.
Am J Gastroenterol.
2006;
101
2060-2069
137
Bargagli E, Margollicci M, Luddi A et al..
Chitotriosidase activity in patients with interstitial lung diseases.
Respir Med.
2007;
101
2176-2181
138
Tercelj M, Salobir B, Simcic S, Wraber B, Zupancic M, Rylander R.
Chitotriosidase activity in sarcoidosis and some other pulmonary diseases.
Scand J Clin Lab Invest.
2009;
69
575-578
139
Tran A, Benzaken S, Saint-Paul M C et al..
Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease.
Eur J Gastroenterol Hepatol.
2000;
12
989-993
140
Johansen J S, Krabbe K S, Møller K, Pedersen B K.
Circulating YKL-40 levels during human endotoxaemia.
Clin Exp Immunol.
2005;
140
343-348
141
Junker N, Johansen J S, Andersen C B, Kristjansen P E.
Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer.
Lung Cancer.
2005;
48
223-231
142
Johansen J S, Milman N, Hansen M, Garbarsch C, Price P A, Graudal N.
Increased serum YKL-40 in patients with pulmonary sarcoidosis—a potential marker of disease activity?.
Respir Med.
2005;
99
396-402
143
Hoffmann K F, McCarty T C, Segal D H et al..
Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions.
FASEB J.
2001;
15
2545-2547
144
Troidl C, Möllmann H, Nef H et al..
Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction.
J Cell Mol Med.
2009;
13
3485-3496
145
Munder M, Eichmann K, Modolell M.
Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype.
J Immunol.
1998;
160
5347-5354
146
Morris Jr S M, Kepka-Lenhart D, Chen L C.
Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells.
Am J Physiol.
1998;
275(5 Pt 1)
E740-E747
147
Dunn M A, Rojkind M, Warren K S, Hait P K, Rifas L, Seifter S.
Liver collagen synthesis in murine schistosomiasis.
J Clin Invest.
1977;
59
666-674
148
Shearer J D, Richards J R, Mills C D, Caldwell M D.
Differential regulation of macrophage arginine metabolism: a proposed role in wound healing.
Am J Physiol.
1997;
272(2 Pt 1)
E181-E190
149
Endo M, Oyadomari S, Terasaki Y et al..
Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung.
Am J Physiol Lung Cell Mol Physiol.
2003;
285
L313-L321
150
Desguerre I, Mayer M, Leturcq F, Barbet J P, Gherardi R K, Christov C.
Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.
J Neuropathol Exp Neurol.
2009;
68
762-773
151
Herbert D R, Hölscher C, Mohrs M et al..
Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology.
Immunity.
2004;
20
623-635
152
Yang M, Rangasamy D, Matthaei K I et al..
Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness.
J Immunol.
2006;
177
5595-5603
153
Zhao A, Urban Jr J F, Anthony R M et al..
Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages.
Gastroenterology.
2008;
135
217-225
154
Abbas A K, Murphy K M, Sher A.
Functional diversity of helper T lymphocytes.
Nature.
1996;
383
787-793
155
Bronte V, Zanovello P.
Regulation of immune responses by L-arginine metabolism.
Nat Rev Immunol.
2005;
5
641-654
156
Gallina G, Dolcetti L, Serafini P et al..
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.
J Clin Invest.
2006;
116
2777-2790
157
Rodriguez P C, Quiceno D G, Zabaleta J et al..
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.
Cancer Res.
2004;
64
5839-5849
158
Mills C D, Kincaid K, Alt J M, Heilman M J, Hill A M.
M-1/M-2 macrophages and the Th1/Th2 paradigm.
J Immunol.
2000;
164
6166-6173
159
Segawa M, Fukada S, Yamamoto Y et al..
Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis.
Exp Cell Res.
2008;
314
3232-3244
160
Zimmermann N, King N E, Laporte J et al..
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis.
J Clin Invest.
2003;
111
1863-1874
161
Nishida M, Okumura Y, Fujimoto S, Shiraishi I, Itoi T, Hamaoka K.
Adoptive transfer of macrophages ameliorates renal fibrosis in mice.
Biochem Biophys Res Commun.
2005;
332
11-16
162
Harty M W, Papa E F, Huddleston H M et al..
Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers.
Surgery.
2008;
143
667-678
163
Mitchell C, Couton D, Couty J P et al..
Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice.
Am J Pathol.
2009;
174
1766-1775
164
Muriel P, Escobar Y.
Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride.
J Appl Toxicol.
2003;
23
103-108
165
Roggin K K, Papa E F, Kurkchubasche A G, Tracy Jr T F.
Kupffer cell inactivation delays repair in a rat model of reversible biliary obstruction.
J Surg Res.
2000;
90
166-173
166
Fallowfield J A, Mizuno M, Kendall T J et al..
Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis.
J Immunol.
2007;
178
5288-5295
167
Madala S K, Pesce J T, Ramalingam T R et al..
Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis.
J Immunol.
2010;
184
3955-3963
168
Cabrera S, Gaxiola M, Arreola J L et al..
Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Int J Biochem Cell Biol.
2007;
39
2324-2338
169
Hironaka K, Sakaida I, Matsumura Y, Kaino S, Miyamoto K, Okita K.
Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis.
Biochem Biophys Res Commun.
2000;
267
290-295
170
Uchinami H, Seki E, Brenner D A, D'Armiento J.
Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
Hepatology.
2006;
44
420-429
171
Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H.
Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats.
Gastroenterology.
2005;
128
138-146
172
Gross T J, Hunninghake G W.
Idiopathic pulmonary fibrosis.
N Engl J Med.
2001;
345
517-525
173
Vaglio A, Salvarani C, Buzio C.
Retroperitoneal fibrosis.
Lancet.
2006;
367
241-251
174
Berenguer M, Aguilera V, Prieto M et al..
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
J Hepatol.
2006;
44
717-722
175
Issa R, Zhou X, Trim N et al..
Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration.
FASEB J.
2003;
17
47-49
Thomas A WynnPh.D.
Immunopathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, MD 20892
eMail: twynn@niaid.nih.gov